Marizyme, Inc.
MRZM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 176.6% | 11% | 6.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 37% | 76.7% | 61.8% | 70.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,585.2% | -14,791.2% | -5,149.4% | -2,641.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10,767.8% | -16,346.2% | -5,230.2% | -2,965% |
| EPS Diluted | -1.53 | -0.94 | -0.31 | -0.22 |
| % Growth | -62.8% | -203.2% | -40.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |